The Kava Anxiety Depression Spectrum Study (KADSS): A Randomized, Placebo-Controlled Crossover Trial Using An Aqueous Extract Of Piper Methysticum

UTSePress Research/Manakin Repository

Search UTSePress Research


Advanced Search

Browse

My Account

Show simple item record

dc.contributor.author Sarris, J en_US
dc.contributor.author Kavanagh, Dj en_US
dc.contributor.author Byrne, G en_US
dc.contributor.author Bone, Km en_US
dc.contributor.author Adams, Jon en_US
dc.contributor.author Deed, G en_US
dc.contributor.editor en_US
dc.date.accessioned 2012-02-10T06:09:37Z
dc.date.available 2012-02-10T06:09:37Z
dc.date.issued 2009 en_US
dc.identifier 2010003354 en_US
dc.identifier.citation Sarris J et al. 2009, 'The Kava Anxiety Depression Spectrum Study (Kadss): A Randomized, Placebo-Controlled Crossover Trial Using An Aqueous Extract Of Piper Methysticum', Springer, vol. 205, no. 3, pp. 399-407. en_US
dc.identifier.issn 0033-3158 en_US
dc.identifier.other C1UNSUBMIT en_US
dc.identifier.uri http://hdl.handle.net/10453/17077
dc.description.abstract Rationale Piper methysticum (Kava) has been withdrawn in European, British, and Canadian markets due to concerns over hepatotoxic reactions. The WHO recently recommended research into aqueous extracts of Kava. Objective The objective of this study was to en_US
dc.language en_US
dc.publisher Springer en_US
dc.relation.isbasedon http://dx.doi.org/10.1007/s00213-009-1549-9 en_US
dc.title The Kava Anxiety Depression Spectrum Study (KADSS): A Randomized, Placebo-Controlled Crossover Trial Using An Aqueous Extract Of Piper Methysticum en_US
dc.parent Psychopharmacology en_US
dc.journal.volume 205 en_US
dc.journal.number 3 en_US
dc.publocation New York en_US
dc.identifier.startpage 399 en_US
dc.identifier.endpage 407 en_US
dc.cauo.name FOH.Faculty of Health en_US
dc.conference Verified OK en_US
dc.for 111700 en_US
dc.personcode 0000068322 en_US
dc.personcode 0000065721 en_US
dc.personcode 0000068323 en_US
dc.personcode 0000068324 en_US
dc.personcode 112076 en_US
dc.personcode 0000068325 en_US
dc.percentage 50 en_US
dc.classification.name Public Health and Health Services en_US
dc.classification.type FOR-08 en_US
dc.edition en_US
dc.custom en_US
dc.date.activity en_US
dc.location.activity ISI:000268120400005 en_US
dc.description.keywords In-Vitro; Disorder; Metaanalysis; Efficacy; Benzodiazepines; Kavalactones; Inventory; Toxicity; Mood en_US
dc.staffid en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record